Wooburn Green, Buckinghamshire, 21 March 2016: Martindale Pharma, the UK-based leading international specialty pharmaceutical company today announced the re-launch of its methadone oral solution product in Scandinavia via its strategic partner Unimedic AB. Martindale Pharma’s methadone oral solution will be available for prescribers from 1 April 2016 in Norway and Sweden and 1 May 2016 in Finland.
Martindale Methadone Oral Solution represents a novel option for patients requiring opioid substitution therapy (OST) for the treatment of opioid addiction. The product is a 2mg/ml, orange flavoured, sugar-free oral liquid and has been noted by prescribers and patients as the preferred treatment solution as existing products can contain large amounts of sugar/other flavours or unwanted additives like alcohol. The product comes in a range of small volumes where one bottle can be used as a single dose.
The re-launch of the product follows a change in excipients used in the formulation as well as the new appointment of Unimedic AB, as Martindale Pharma’s partner for this product range in Scandinavia. This partnership expands a successfully established relationship with Unimedic AB for the marketing of Martindale Pharma’s sterile injection products. Commenting on the launch Michael Harris, CEO of Martindale Pharma said:
“We are very pleased to expand our portfolio of opioid addiction treatments by the re-introduction of this methadone product into Scandinavia. Martindale Pharma’s comprehensive range of methadone products have been formulated to meet multiple patient, pharmacists and prescriber needs and the re-launch of this product marks our on-going commitment to providing patients with safe and effective treatments.
Our experience and breadth of product portfolio make us a market leader and highly trusted supplier of opioid addiction products in the UK and Scandinavia, and we are actively seeking to expand our commercial agreements in Europe for this part of our business.”
ENDS
Notes to editors
About Martindale Pharma®
Martindale Pharma is a leading UK-based, international specialty pharmaceutical company providing essential medicines to over 28 countries around the world.
Our strategy is to build leading positions in defined business segments where there is a high unmet medical need and a demand for improved product presentations. Our focus is on Opioid Addiction, Emergency Care, Hospital-initiated Medicines, Ophthalmics and Unlicensed Medicines (also called “Specials”).
We have a strong UK presence with expertise in marketing hospital and specialty medicines. We are recognised as a strategic partner to the NHS and other healthcare providers and supplying over 100 licensed products and we have a track record of successful new product launches.
We have a rapidly growing international business currently centred on three geographical regions: Saudi Arabia and the Gulf Co-Operation Council territory, Australia and South East Asia and Northern Europe (focused on Scandinavia). The business is underpinned by our own modern, efficient UK manufacturing facility which enables us to develop and compete globally to supply high quality, low cost specialty pharmaceuticals in sterile injection and oral liquid formats. For further information visit our website www.martindalepharma.co.uk
About Unimedic AB
Unimedic Pharma is a Swedish pharmaceutical company focusing on the Nordic market, providing a wide range of non-licensed, extemporanious and licensed pharmaceuticals based on the needs and requirements from the healthcare professionals.
The Unimedic Group has many years of experience and extensive expertise within the manufacturing, development, distribution, sales and marketing of pharmaceuticals. The company is, today, one of the fastest growing pharmaceutical companies within the Nordic market and has, over the past three years, increased the turnover from MSEK 100 to MSEK 600. The founding of a district laboratory in Matfors in the mid-1960s was the start of pharmaceutical operations. For further information visit: http://www.unimedic.se/en/
